150 Hikma PHarmaceuticals Plc annual report 2011 notes to the company financialstatements Continued 50. financial policies for risk management and their objectives currency risk currency risks as defined by ifrs 7 arise on account of financial instruments being denominated in a currency that is not thefunctional currency and being of a monetary nature.
the following table illustrates financial assets and liabilities for the company in differentcurrencies: liabilities assets 2011 2010 2011 2010 $000 $000 $000 $000 euro 1,992 125 british pound 1,537 1,191 159 580 jordanian dinar 31 21 a sensitivity analysis based on a 1% movement in foreign exchange rates has no material impact on the company results and company statement of changes in equity.
further details on how the company manages the currency risk are given in note 29 to the Group accounts.
interest rate risk: an interest rate sensitivity analysis assumes an instantaneous 100 basis point change in interest rates in all currencies fromtheir levels at 31 December 2011, with all other variables held constant.
Based on the composition of the company debt portfolio as at 31December 2011, a 1% increase decrease in interest rates would result in an additional interest expense income of usD 1.4 million being incurred per year 2010: usD nil.
liquidity risk less than two to more than one year five years five years total 2011 $000 $000 $000 $000 cash and cash equivalents 6,091 6,091 accounts receivables 92 92 interest-bearing loans and borrowings 4,341 83,053 70,495 157,889 other payables 412 412 1,430 83,053 70,495 152,118 less than two to more than one year five years five years total 2010 $000 $000 $000 $000 cash and cash equivalents 3,063 3,063 accounts receivables 93 93 other payables 255 255 2,901 2,901 the company believes that, given the Groups forecast operating cash flow during 2012, it has the ability to satisfy its liability commitments.
51. staff costs Hikma Pharmaceuticals Plc currently has ten employees 2010: eight excluding executive Directors : total compensation paid to them amounted to usD 1,890,000 2010: usD 1,660,000 of which salaries and wages compromise an amount of usD 1,291,000 2010: usD 1,192,000 the remaining balance of usD 599,000 2010: usD 468,000 represent national insurance contributions, the cost of share-based payments and otherbenefits.
52. stock options the details of the stock compensation scheme are provided in note 36 to the Group accounts.
as at 31 December 2011, the total number ofoptions granted to employees of the company under the stock compensation scheme during the life of the scheme was 2,560,000 2010:2,560,000 and the total amount of the compensation expenses charged to the statement of comprehensive income is usD nil 2010:usD24,719.
